Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by studpuppyon Jan 11, 2010 9:00pm

346 Views

Post# 16666518

RE: RE: TH on BNN

i guess that explains todays spike that occured after 3pm, anyway lmz its really nice lately with TH and hopefully it will be awesome come march for all of us shareholders because it has been a rough couple of years, they are getting more and more visibility and the closer we get the more we will here about TH, good luck to all the longs whom have been very patient with this stock!
regards stud

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario